T80.82XD
Complication of immune effector cellular therapy, subsequent encounter
- Release
- FY 2027
- Effective
Hierarchy
Where T80.82XD sits in the official hierarchy. Each level is the code it is classified under.
- T80 Complications following infusion, transfusion and therapeutic injection
- T80.8 Other complications following infusion, transfusion and therapeutic injection
- T80.82 Parent Complication of immune effector cellular therapy
- T80.82XD This code Complication of immune effector cellular therapy, subsequent encounter
Official Coding Notes
Reproduced verbatim from the FY 2027 ICD-10-CM files. Notes labelled as inherited are declared on a parent code and apply here too.
Includes
complications following perfusion
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
bone marrow transplant rejection ( T86.01 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
adverse effect of immune checkpoint inhibitors and immunostimulant drugs ( T45.AX5 )
Inherited from T80.82 — Complication of immune effector cellular therapy
Excludes2
febrile nonhemolytic transfusion reaction ( R50.84 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
complication of bone marrow transplant ( T86.0 )
Inherited from T80.82 — Complication of immune effector cellular therapy
Excludes2
fluid overload due to transfusion ( E87.71 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
complication of stem cell transplant ( T86.5 )
Inherited from T80.82 — Complication of immune effector cellular therapy
Excludes2
posttransfusion purpura ( D69.51 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Excludes2
transfusion associated circulatory overload (TACO) ( E87.71 )
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Use Additional Code
code to identify the specific complication, such as:
Inherited from T80.82 — Complication of immune effector cellular therapy
7th Character
The appropriate 7th character is to be added to each code from category T80
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
7th Character
A - initial encounter
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
7th Character
D - subsequent encounter
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
7th Character
S - sequela
Inherited from T80 — Complications following infusion, transfusion and therapeutic injection
Version History
How T80.82XD appears in each release imported from the official files, newest first.
-
FY 2027 Effective
CurrentComplication of immune effector cellular therapy, subsequent encounter
-
FY 2026 Effective
UnchangedComplication of immune effector cellular therapy, subsequent encounter
Related Codes
Data Source
Code information on this page is derived from the FY 2027 ICD-10-CM files published by CDC NCHS and CMS.
- Release
- FY 2027
- Effective
- Source file
- icd10cm-code-descriptions-2027.zip
Official ICD-10-CM source files (opens in a new tab)
MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.
Look up another code
Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.